发明申请
- 专利标题： IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
- 专利标题（中）： 用于治疗变应性和炎症性疾病的咪唑吡嗪化合物
-
申请号： US12970659申请日： 2010-12-16
-
公开(公告)号： US20110218178A1公开(公告)日： 2011-09-08
- 发明人: Martin James Inglis Andrews , Paul Edwards , Reginald Christophe Xavier Brys , Philip Huxley , Wolfgang Schmidt , Veronique Birault , Mark Stuart Chambers , Clifford John Harris , Angus Macleod , Kim Louise Hirst , Juha Andrew Clase , Gregory Bar
- 申请人： Martin James Inglis Andrews , Paul Edwards , Reginald Christophe Xavier Brys , Philip Huxley , Wolfgang Schmidt , Veronique Birault , Mark Stuart Chambers , Clifford John Harris , Angus Macleod , Kim Louise Hirst , Juha Andrew Clase , Gregory Bar
- 专利权人： JANSSEN PHARMACEUTICA NV
- 当前专利权人： JANSSEN PHARMACEUTICA NV
- 主分类号： A61K31/635
- IPC分类号： A61K31/635 ; C07D487/04 ; A61K31/4985 ; C07D413/14 ; A61K31/5377 ; A61P19/02 ; A61P29/00
摘要：
Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.